Stock CALTX CALLIDITAS THERAPEUTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Calliditas Therapeutics AB

Equities

CALTX

SE0010441584

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:52 2024-05-03 am EDT 		5-day change 1st Jan Change
106.6 SEK -1.93% Intraday chart for Calliditas Therapeutics AB +2.80% -16.13%
May. 02 European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading MT
Apr. 25 European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
MT
Calliditas Therapeutics AB Announces Positive NefIgArd Open Label Extension Results
CI
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
MT
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
CI
Calliditas Therapeutics AB Presents Additional Data Analyses from the Phase 3 NeflgArd Trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
CI
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
MT
Calliditas Therapeutics AB to Present Nefecon Data At the ISN World Congress of Nephrology in Buenos Aires
CI
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower
MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading
MT
Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®
CI
Calliditas Therapeutics Says Kidney Disease Drug Granted Seven-Year Exclusivity Period by FDA
MT
Calliditas Therapeutics AB Announces an Additional Seven Year Orphan Drug Exclusivity Period for TARPEYO
CI
Travere drug for rare kidney condition recommended for EU approval
RE
Calliditas Therapeutics AB Provides Revenue Guidance for the Year Ending December 31, 2024
CI
Calliditas Therapeutics AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CALTX Stock
  4. News Calliditas Therapeutics AB
  5. Highlights